NovaBay Pharmaceuticals (NYSE:NBY) announced on Tuesday that it has received an unsolicited, non-binding offer from Refresh ...

EMERYVILLE, Calif., November 07, 2024--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) reports financial results for the three and nine months ended September 30, 2024. EMERYVILLE ...

加利福尼亚州埃默里维尔 - 制药公司NovaBay Pharmaceuticals, Inc. (NYSE American: NBY)今天宣布，已同意PRN Physician Recommended Nutriceuticals, ...

NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) ("NovaBay" or the "Company") announces that the Company’s board of directors has determined that an unsolicited and non-binding offer from Refresh ...

NBY opened at $0.75 on Friday. NovaBay Pharmaceuticals has a twelve month low of $0.36 and a twelve month high of $12.84. The company has a 50-day simple moving average of $0.59 and a 200 day ...

Novabay(NBY)发布Q3财报，2024财年前三财季累计收入747.20万美元，去年同期累计收入为835.40万美元，同比减少10.56%。 2024财年前三财季累计净亏损601.10万美元，去年同期累计净亏损为553.20万美元，同比扩大8.66%。 本财年累计基本每股收益为-3.97美元，去年同期为-79.58美元。 公司所属行业为制药。 Novabay Pharmaceuticals, ...

On Tuesday, NovaBay Pharmaceuticals Inc (NBY) stock saw a modest uptick, ending the day at $0.65 which represents a slight increase of $0.10 or 18.18% from the prior close of $0.55. The stock opened ...

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY) (“NovaBay” or the “Company”) today announces that the Company has ...

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY) (“NovaBay” or the “Company”) announces that the Company’s board ...

EMERYVILLE, Calif. - NovaBay Pharmaceuticals, Inc. (NYSE American: NBY), a pharmaceutical company, announced today that it has agreed to a revised offer from PRN Physician Recommended ...